Van Nevel Retires as NCI Communications Chief

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

BETHESDA, Md—J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

NCI director Richard D. Klausner, MD, praised Mr. Van Nevel at the National Cancer Advisory Board meeting and thanked him for his contributions to the Institute. Dr. Klausner noted that Mr. Van Nevel would “help us negotiate the transition to the post-Paul Van Nevel era at NCI.”

Mr. Van Nevel joined NCI as deputy director of communications in 1973, following 5 years in media relations at Johns Hopkins. He was named head of NCI’s communications office in 1974. Nelvis Castro, chief of NCI’s health promotion branch, will serve as acting associate director for cancer communications.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content